News
The U.S. Food and Drug Administration’s (FDA’s) evolving guidance on Computer Software Assurance and AI/ML-Based Software ...
Price differences are especially pertinent with these weight loss drugs, which are officially called glucagon-like peptide-1 ...
As the pharma sector braces for sector-specific tariffs from President Trump, what could the impact look like on supply ...
Proposals for drug exclusivities and feeble measures to combat drug shortages are unlikely to boost innovation, say some ...
The evolving landscape of vaccine oversight makes it key to maintain public trust and keep scientific integrity at the ...
Sanofi's antibody riliprubart has received orphan drug designation from Japan's MHLW for its potential to treat CIDP.
Scientific experts are concerned about what role vaccines will play in US public health strategy under the Trump ...
Vetter Pharma, has begun the construction of a new clinical manufacturing facility in Des Plaines, Illinois, US.
A new podcast from industry experts MarketScan explains why social determinants of health are critical to patient care.
Modella AI has signed a multi-year agreement with AstraZeneca for expediting AI-driven oncology clinical development.
AbbVie gains control of an in vivo CAR-T therapy that could overcome limitations with currently approved autologous ...
The FDA has approved Sobi's Gamifant (emapalumab) to treat adults and children with HLH/MAS associated with Still’s disease, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results